Search results for "cancer diagnosis"
Selected Filters:
Rabbit anti-human mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) polyclonal Antibody
- Manufacturer
- MyBioSource
- Catalog Number
- MBS711248
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- ELISA, Western Blotting
Rabbit anti-human mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) polyclonal Antibody
- Manufacturer
- MyBioSource
- Catalog Number
- MBS714473
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- ELISA, Immunofluorescence, Immunohistochemistry, Western Blotting
Clinical testing: How reliable and inventory-friendly methods are helping overcome post-pandemic hurdles
Find out how using the right tools can help address the biggest challenges in the world of molecular diagnostics
90% reduction in greenhouse gas emissions for the treatment of biohazardous waste
Independent assessment of pharmaceutical, diagnostic and hospital facilities demonstrate that GENERATIONS, significantly impacts on waste-related Scope 3 emissions
Digital PCR method could help with selecting rapid malaria tests
A new method for screening the genomes of malaria parasites could help malaria programs select the best diagnostic tests
Is the effort really worth the result: hs-cTn at the point of care or lab
Hear three experts discuss the use of high- sensitivity cardiac troponin as a diagnostic tool in the emergency department
5 top webinars coming up this week
Explore hot topics from 3D X-ray microscopy and in vitro diagnostics to gas chromatography and synthetic guide RNAs
How to tackle the emerging COVID-19 variants
Arvind Kothandaraman discusses the importance of detecting new SARS-CoV-2 variants and future trends in COVID-19 diagnostics
Dealing with unpredictability: Manufacturing COVID-19 lateral flow tests during the pandemic
An insider’s look into the bottlenecks and challenges associated with manufacturing and supply chain workflows within lateral flow diagnostics
BD launches portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19
BD launches portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes, dramatically expanding access to COVID-19 testing
This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19
LGC expands SARS-CoV-2 serology offering with 11-member positive-patient Performance Panel
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Sherlock Biosciences, IDT collaborate to manufacture CRISPR-based SARS-CoV-2 testing kits
Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide
therascreen KRAS RGQ PCR Kit
QIAGENThe therascreen KRAS RGQ PCR Kit is a real-time, qualitative in vitro diagnostic test for the detection of 7 somatic mutations in the KRAS oncogene using a sample of DNA extracted from formalin-fixed, paraffin-embedded (FPPE) non-small cell lung cancer (NSCLC) tissue and colorectal cancer (CRC) tissue.